Literature DB >> 30039599

Sarcopenia is associated with blood pressure variability in older patients with type 2 diabetes: A cross-sectional study of the KAMOGAWA-DM cohort study.

Yoshitaka Hashimoto1, Ayumi Kaji1, Ryosuke Sakai1, Masahide Hamaguchi1,2, Hiroshi Okada1,3, Emi Ushigome1, Mai Asano1, Masahiro Yamazaki1, Michiaki Fukui1.   

Abstract

AIM: To investigate the association between sarcopenia and blood pressure parameters in older patients with type 2 diabetes.
METHODS: This was a cross-sectional study of 146 older patients with diabetes. Body composition was evaluated by bioimpedance analysis. The skeletal muscle mass index (kg/m2 ) was defined as appendicular muscle mass / the square of the height. Patients with both handgrip strength <26 kg for men and <18 kg for women, and skeletal muscle mass index <7.0 kg/m2 for men and <5.7 kg/m2 for women were diagnosed as sarcopenia. We measured systolic blood pressure (SBP) at every visit for 1 year and calculated the coefficient of variation of SBP.
RESULTS: Among 146 patients (86 men and mean age 72.6 years [SD 5.9 years], 21 patients (14.4%) were sarcopenic. The coefficient of variation of SBP in patients with sarcopenia was higher than that in patients without sarcopenia (9.1 [SD 3.2] vs 7.1 [SD 2.9]%, P = 0.007), although the average SBP of patients with sarcopenia and that of patients without sarcopenia was not different (129.5 [SD 14.0] vs 130.5 [SD 12.9] mmHg, P = 0.558). Multiple regression analysis showed that sarcopenia was associated with the coefficient of variation of SBP (β = 0.20, P = 0.024), even after adjusting for covariates, whereas sarcopenia was not associated with the average SBP (β = 0.05, P = 0.558).
CONCLUSIONS: We showed that sarcopenia was associated with blood pressure variability, whereas not with the average SBP. It is necessary for clinicians to pay careful attention to blood pressure variability when examining patients with sarcopenia. Geriatr Gerontol Int 2018; 18: 1345-1349.
© 2018 Japan Geriatrics Society.

Entities:  

Keywords:  blood pressure variability; elderly; muscle; sarcopenia

Mesh:

Year:  2018        PMID: 30039599     DOI: 10.1111/ggi.13487

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN: 1447-0594            Impact factor:   2.730


  15 in total

1.  Impact of Eating Speed on Muscle Mass in Older Patients With Type 2 Diabetes: A Prospective Study of KAMOGAWA-DM Cohort.

Authors:  Genki Kobayashi; Yoshitaka Hashimoto; Fuyuko Takahashi; Ayumi Kaji; Ryosuke Sakai; Takuro Okamura; Hiroshi Okada; Noriyuki Kitagawa; Naoko Nakanishi; Saori Majima; Takafumi Osaka; Takafumi Senmaru; Emi Ushigome; Mai Asano; Masahide Hamaguchi; Masahiro Yamazaki; Michiaki Fukui
Journal:  Front Nutr       Date:  2022-06-23

Review 2.  A Narrative Review on Sarcopenia in Type 2 Diabetes Mellitus: Prevalence and Associated Factors.

Authors:  Anna Izzo; Elena Massimino; Gabriele Riccardi; Giuseppe Della Pepa
Journal:  Nutrients       Date:  2021-01-09       Impact factor: 5.717

3.  Orthostatic hypotension and age-related sarcopenia.

Authors:  Kudret Keskin; Selda Çiftçi; Jülide Öncü; Güneş Melike Doğan; Gökhan Çetinkal; Süleyman Sezai Yıldız; Serhat Sığırcı; Kadriye Orta Kılıçkesmez
Journal:  Turk J Phys Med Rehabil       Date:  2021-03-04

4.  Effect of COVID-19 Pandemic on the Change in Skeletal Muscle Mass in Older Patients with Type 2 Diabetes: A Retrospective Cohort Study.

Authors:  Yuka Hasegawa; Fuyuko Takahashi; Yoshitaka Hashimoto; Chihiro Munekawa; Yukako Hosomi; Takuro Okamura; Hiroshi Okada; Takafumi Senmaru; Naoko Nakanishi; Saori Majima; Emi Ushigome; Masahide Hamaguchi; Masahiro Yamazaki; Michiaki Fukui
Journal:  Int J Environ Res Public Health       Date:  2021-04-15       Impact factor: 3.390

5.  Habitual Miso (Fermented Soybean Paste) Consumption Is Associated with a Low Prevalence of Sarcopenia in Patients with Type 2 Diabetes: A Cross-Sectional Study.

Authors:  Fuyuko Takahashi; Yoshitaka Hashimoto; Ayumi Kaji; Ryosuke Sakai; Yuka Kawate; Takuro Okamura; Noriyuki Kitagawa; Hiroshi Okada; Naoko Nakanishi; Saori Majima; Takafumi Senmaru; Emi Ushigome; Masahide Hamaguchi; Mai Asano; Masahiro Yamazaki; Michiaki Fukui
Journal:  Nutrients       Date:  2020-12-28       Impact factor: 5.717

6.  Home-Measured Blood Pressure Is Associated with Handgrip Strength in Patients with Type 2 Diabetes: The KAMOGAWA-HBP Study.

Authors:  Tomonori Kimura; Emi Ushigome; Yoshitaka Hashimoto; Naoko Nakanishi; Masahide Hamaguchi; Mai Asano; Masahiro Yamazaki; Michiaki Fukui
Journal:  J Clin Med       Date:  2021-04-28       Impact factor: 4.241

7.  The association of grip strength with cardiovascular diseases and all-cause mortality in people with hypertension: Findings from the Prospective Urban Rural Epidemiology China Study.

Authors:  Weida Liu; Darryl P Leong; Bo Hu; Lap AhTse; Sumathy Rangarajan; Yang Wang; Chuangshi Wang; Fanghong Lu; Yindong Li; Salim Yusuf; Lisheng Liu; Wei Li
Journal:  J Sport Health Sci       Date:  2020-10-19       Impact factor: 7.179

8.  Japanese radio calisthenics prevents the reduction of skeletal muscle mass volume in people with type 2 diabetes.

Authors:  Tomonori Kimura; Takuro Okamura; Keiko Iwai; Yoshitaka Hashimoto; Takafumi Senmaru; Emi Ushigome; Masahide Hamaguchi; Mai Asano; Masahiro Yamazaki; Michiaki Fukui
Journal:  BMJ Open Diabetes Res Care       Date:  2020-02

9.  Reduction of Fat to Muscle Mass Ratio Is Associated with Improvement of Liver Stiffness in Diabetic Patients with Non-Alcoholic Fatty Liver Disease.

Authors:  Takafumi Osaka; Yoshitaka Hashimoto; Takuro Okamura; Takuya Fukuda; Masahiro Yamazaki; Masahide Hamaguchi; Michiaki Fukui
Journal:  J Clin Med       Date:  2019-12-09       Impact factor: 4.241

10.  Impact of extracellular-to-intracellular fluid volume ratio on albuminuria in patients with type 2 diabetes: A cross-sectional and longitudinal cohort study.

Authors:  Hanako Nakajima; Yoshitaka Hashimoto; Ayumi Kaji; Ryosuke Sakai; Fuyuko Takahashi; Yuta Yoshimura; Ryo Bamba; Takuro Okamura; Noriyuki Kitagawa; Saori Majima; Takufumi Senmaru; Hiroshi Okada; Naoko Nakanishi; Emi Ushigome; Mai Asano; Masahide Hamaguchi; Masahiro Yamazaki; Michiaki Fukui
Journal:  J Diabetes Investig       Date:  2020-11-28       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.